SCHEMBL13020670

SCHEMBL13020670

CC1[C@@H](COP(C)C)O[C@@H](C)[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020667 0.74 — —
SCHEMBL13218871 0.73 — —
SCHEMBL13020673 0.71 FBP1 (0.34) —
SCHEMBL23314202 0.71 — —
SCHEMBL12386244 0.70 ALDH1A1 (0.40) —
SCHEMBL16688374 0.70 — —
SCHEMBL15497752 0.69 HSD17B10 (0.39) —
SCHEMBL16559143 0.69 HSD17B10 (0.39) —
SCHEMBL18718088 0.68 — —
SCHEMBL13882742 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331397-A1 2-5A ANALOGS AND THEIR METHODS OF USE ALIOS BIOPHARMA, INC. (US) 2010-12-30 — — US disclosed
Send feedback